NCT01291472View on ClinicalTrials.gov

Disposition of Intravenous Ketorolac

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Postoperative Pain
Interventions
DRUG

Ketorolac Tromethamine

After dilution (solution for injection, 10 mg/1ml) in 50-100 ml bag of normal saline drug will be administered by iv bolus, through a peripherally inserted venous catheter, 30 mg, 3 times in one day. The intended duration of administration is 5-10 minutes.

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01291472 - Disposition of Intravenous Ketorolac | Biotech Hunter | Biotech Hunter